Asset Allocation

As of June 30, 2026.
Type % Net
Cash 12.53%
Stock 10.81%
Bond 71.28%
Convertible 0.00%
Preferred 2.10%
Other 3.28%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 78.36%    % Emerging Markets: 0.26%    % Unidentified Markets: 21.39%

Americas 66.03%
63.68%
Canada 3.51%
United States 60.17%
2.36%
As of June 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 12.56%
United Kingdom 1.25%
11.31%
Denmark 0.00%
France -0.01%
Germany 4.67%
Ireland 0.00%
Italy 0.00%
Netherlands -0.01%
Norway 2.24%
Spain 0.19%
Sweden 3.32%
Switzerland 0.00%
0.00%
0.00%
Israel 0.00%
Greater Asia 0.02%
Japan -0.01%
0.04%
Australia 0.04%
-0.01%
Hong Kong 0.00%
Singapore 0.00%
0.00%
Unidentified Region 21.39%

Bond Credit Quality Exposure

AAA 0.71%
AA 5.67%
A -0.53%
BBB 10.79%
BB 14.85%
B 17.14%
Below B 3.11%
    CCC 3.11%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 48.27%
Short Term 0.00%
As of June 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
8.17%
Materials
1.12%
Consumer Discretionary
-0.25%
Financials
5.11%
Real Estate
2.19%
Sensitive
11.24%
Communication Services
2.29%
Energy
8.41%
Industrials
0.00%
Information Technology
0.54%
Defensive
0.00%
Consumer Staples
0.00%
Health Care
0.00%
Utilities
0.00%
Not Classified
49.03%
Non Classified Equity
49.03%
As of June 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of June 30, 2026
Type % Net
Government 7.74%
Corporate 72.04%
Securitized 0.43%
Municipal 0.00%
Other 19.80%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
11.18%
Less than 1 Year
11.18%
Intermediate
87.76%
1 to 3 Years
35.44%
3 to 5 Years
34.18%
5 to 10 Years
18.14%
Long Term
1.05%
10 to 20 Years
0.43%
20 to 30 Years
0.14%
Over 30 Years
0.48%
Other
0.00%
As of June 30, 2026
View Bond Maturity Exposure
Start Trial